- Home
- OSS vs OLMA Comparison
OSS vs OLMA Comparison
Compare OSS & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSS
- OLMA
- Stock Information
- Founded
- OSS 1998
- OLMA 2006
- Country
- OSS United States
- OLMA United States
- Employees
- OSS N/A
- OLMA N/A
- Industry
- OSS Computer Manufacturing
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- OSS Technology
- OLMA Health Care
- Exchange
- OSS Nasdaq
- OLMA Nasdaq
- Market Cap
- OSS 84.2M
- OLMA 299.7M
- IPO Year
- OSS 2018
- OLMA 2020
- Fundamental
- Price
- OSS $4.91
- OLMA $4.65
- Analyst Decision
- OSS
- OLMA Strong Buy
- Analyst Count
- OSS 0
- OLMA 4
- Target Price
- OSS N/A
- OLMA $24.50
- AVG Volume (30 Days)
- OSS 607.5K
- OLMA 825.6K
- Earning Date
- OSS 08-07-2025
- OLMA 08-05-2025
- Dividend Yield
- OSS N/A
- OLMA N/A
- EPS Growth
- OSS N/A
- OLMA N/A
- EPS
- OSS N/A
- OLMA N/A
- Revenue
- OSS $54,301,661.00
- OLMA N/A
- Revenue This Year
- OSS $8.73
- OLMA N/A
- Revenue Next Year
- OSS $12.37
- OLMA N/A
- P/E Ratio
- OSS N/A
- OLMA N/A
- Revenue Growth
- OSS N/A
- OLMA N/A
- 52 Week Low
- OSS $1.82
- OLMA $2.86
- 52 Week High
- OSS $5.23
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- OSS 66.21
- OLMA 52.46
- Support Level
- OSS $3.87
- OLMA $4.38
- Resistance Level
- OSS $4.30
- OLMA $5.01
- Average True Range (ATR)
- OSS 0.33
- OLMA 0.30
- MACD
- OSS -0.01
- OLMA 0.05
- Stochastic Oscillator
- OSS 78.99
- OLMA 63.64
About OSS One Stop Systems Inc.
One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.